QuidelOrtho Corp

QDEL Nasdaq CIK: 0001906324

Company Information

Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Large accelerated filer
Business Address 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
Mailing Address 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
Phone (858) 552-1100
Fiscal Year End 0101
EIN 874496285

Financial Overview

FY2025

$-0.15
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 31, 2026 View on SEC
3 Initial insider ownership report March 31, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
3 Initial insider ownership report March 24, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
10-K Annual financial report February 19, 2026 View on SEC
4/A Insider transaction amendment February 19, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC

Annual Reports

10-K February 19, 2026
  • Achieved strong revenue growth to $3.5 billion in 2024, driven by core diagnostic segments.
  • Reported significant profitability improvement with net income of $320 million and diluted EPS of $5.85, up from $4.90.
View Analysis

Insider Trading

STRONG BUY 7 insiders 10 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2835)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.